169 related articles for article (PubMed ID: 34649577)
1. Facilitators and barriers to the regulation of medical cannabis: a scoping review of the peer-reviewed literature.
Ruheel MA; Gomes Z; Usman S; Homayouni P; Ng JY
Harm Reduct J; 2021 Oct; 18(1):106. PubMed ID: 34649577
[TBL] [Abstract][Full Text] [Related]
2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
3. The use of cannabis in response to the opioid crisis: A review of the literature.
Vyas MB; LeBaron VT; Gilson AM
Nurs Outlook; 2018; 66(1):56-65. PubMed ID: 28993073
[TBL] [Abstract][Full Text] [Related]
4. Exploration of facilitators and barriers to the regulatory frameworks of dietary and herbal supplements: a scoping review.
Ng JY; Kim M; Suri A
J Pharm Policy Pract; 2022 Sep; 15(1):55. PubMed ID: 36064655
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of medical students' and professionals' attitudes and knowledge regarding medical cannabis.
Weisman JM; Rodríguez M
J Cannabis Res; 2021 Oct; 3(1):47. PubMed ID: 34641976
[TBL] [Abstract][Full Text] [Related]
6. Negative experiences of patients using medicinal cannabis: A systematic review of qualitative studies.
Gliksberg O; Kushnir T; Sznitman SR; Lev-Ran S; Brill S; Amit BH; Feingold D
J Clin Nurs; 2023 Sep; 32(17-18):5607-5618. PubMed ID: 36807590
[TBL] [Abstract][Full Text] [Related]
7. Perceptions and engagement of patients with chronic conditions on the use of medical cannabis: a scoping review.
Pomey MP; Jutras-Aswad D; Paquette J; Saadi K; Taguemout M; Ikene DL; Arbour N; Zertal A; Fréjeau N; Morin D; Ouellette JS; Alami Marrouni K; Duquette P
Eur J Med Res; 2024 Apr; 29(1):211. PubMed ID: 38561859
[TBL] [Abstract][Full Text] [Related]
8. Barriers and Facilitators to Health-Care Provider Payment Reform - A Scoping Literature Review.
Ndayishimiye C; Tambor M; Dubas-Jakóbczyk K
Risk Manag Healthc Policy; 2023; 16():1755-1779. PubMed ID: 37701321
[TBL] [Abstract][Full Text] [Related]
9. Effects of medical and non-medical cannabis use in older adults: protocol for a scoping review.
Wolfe D; Corace K; Rice D; Smith A; Kanji S; Conn D; Willows M; Garber GE; Puxty J; Moghadam E; Skidmore B; Garritty C; Thavorn K; Moher D; Hutton B
BMJ Open; 2020 Feb; 10(2):e034301. PubMed ID: 32114474
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Medical Students' Perceptions About Medical Cannabis.
Jacobs RJ; Kane MN; Caballero J
Cureus; 2022 Apr; 14(4):e24390. PubMed ID: 35619867
[TBL] [Abstract][Full Text] [Related]
11. Perspectives of Orthopedic Patients on Medical Cannabis: A Survey of More Than 2500 Patients.
Townsend CB; Liss F; Langman C; Mazur D; Stache SA; Sharma S; Stolzenberg DS; Srinivasan M; Pedowitz D; Namdari S; Wang ML; Greis AC; Ilyas AM
Orthopedics; 2022; 45(6):e309-e314. PubMed ID: 36098574
[TBL] [Abstract][Full Text] [Related]
12. Physicians' experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review.
Rønne ST; Rosenbæk F; Pedersen LB; Waldorff FB; Nielsen JB; Riisgaard H; Søndergaard J
BMC Fam Pract; 2021 Oct; 22(1):212. PubMed ID: 34674661
[TBL] [Abstract][Full Text] [Related]
13. Knowledge, attitudes, and prescribing patterns of cannabis and cannabinoid-containing medicines among European healthcare workers: a systematic literature review.
Hordowicz M; Klimkiewicz A; Jarosz J; Wysocka M; Jastrzębska M
Drug Alcohol Depend; 2021 Apr; 221():108652. PubMed ID: 33667785
[TBL] [Abstract][Full Text] [Related]
14. Medical Marijuana programs: implications for cannabis control policy--observations from Canada.
Fischer B; Kuganesan S; Room R
Int J Drug Policy; 2015 Jan; 26(1):15-9. PubMed ID: 25287942
[TBL] [Abstract][Full Text] [Related]
15. Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review.
Leece P; Khorasheh T; Corace K; Strike C; Bayoumi AM; Taha S; Marks E; Pach B; Ahamad K; Grennell E; Holowaty M; Manson H; Straus SE
BMJ Open; 2019 Dec; 9(12):e032285. PubMed ID: 31843837
[TBL] [Abstract][Full Text] [Related]
16. Six policy lessons relevant to cannabis legalization.
Shover CL; Humphreys K
Am J Drug Alcohol Abuse; 2019; 45(6):698-706. PubMed ID: 30870053
[No Abstract] [Full Text] [Related]
17. Ethical issues in medical cannabis use.
Sagy I; Peleg-Sagy T; Barski L; Zeller L; Jotkowitz A
Eur J Intern Med; 2018 Mar; 49():20-22. PubMed ID: 29482739
[TBL] [Abstract][Full Text] [Related]
18. Provider- and Patient-Related Barriers to and Facilitators of Digital Health Technology Adoption for Hypertension Management: Scoping Review.
Palacholla RS; Fischer N; Coleman A; Agboola S; Kirley K; Felsted J; Katz C; Lloyd S; Jethwani K
JMIR Cardio; 2019 Mar; 3(1):e11951. PubMed ID: 31758771
[TBL] [Abstract][Full Text] [Related]
19. A theoretical analysis of the barriers and facilitators to the implementation of school-based physical activity policies in Canada: a mixed methods scoping review.
Weatherson KA; Gainforth HL; Jung ME
Implement Sci; 2017 Mar; 12(1):41. PubMed ID: 28347322
[TBL] [Abstract][Full Text] [Related]
20. A Survey of Hospice Professionals Regarding Medical Cannabis Practices.
Costantino RC; Felten N; Todd M; Maxwell T; McPherson ML
J Palliat Med; 2019 Oct; 22(10):1208-1212. PubMed ID: 31094609
[No Abstract] [Full Text] [Related]
[Next] [New Search]
